Modulus Therapeutics

Modulus Therapeutics is designing the next generation of immune cell therapies. The company is committed to inventing new methods to engineer immune cell therapies, leveraging gene editing and machine learning to converge cells with optimal performance. Convergent DesignTM combines genetic engineering, machine learning, and high-throughput in vivo screening to systematically integrate optimized cell designs. Modulus Therapeutics is dedicated to discovering cell therapies to treat a broad patient population currently underserved by existing treatments and plans to use its platform to develop an internal therapy pipeline and provide support to partners.